Dose-dependent urinary phenotype of inorganic arsenic methylation in mice with a focus on trivalent methylated metabolites

References

• Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D, Aposhian MM. 2000. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13:693–697.
   PubMed Web of Science ®Google Scholar
• ATSDR (Agency for Toxic Substances and Disease Registry). (2000). Toxicological Profile for Arsenic. US. Department of Health and Human Services.
   Google Scholar
• Bae ON, Lim KM, Noh JY, Chung SM, Kim SH, Chung JH. 2009. Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation. Toxicol Appl Pharmacol 239:144–153.
   PubMed Web of Science ®Google Scholar
• Crecelius EA. 1977. Changes in the chemical speciation of arsenic following ingestion by man. Environ Health Perspect 19:147–150
   PubMed Web of Science ®Google Scholar
• Currier JM, Svoboda M, de Moraes DP, Matousek T, Dedina J, Stýblo M. 2011. Direct analysis of methylated trivalent arsenicals in mouse liver by hydride generation-cryotrapping-atomic absorption spectrometry. Chem Res Toxicol 24:478–480.
   PubMed Web of Science ®Google Scholar
• Del Razo LM, García-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, Ostrosky-Wegman P, Kelsh M, Cebrián ME. 1997. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol 71:211–217.
   PubMed Web of Science ®Google Scholar
• Del Razo LM, Styblo M, Cullen WR, Thomas DJ. 2001. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 174:282–293.
   PubMed Web of Science ®Google Scholar
• Devesa V, Del Razo LM, Adai B, Drobná Z, Waters SB, Hughes MF, Stýblo M, Thomas DJ. 2004. Comprehensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry. J Anal Atom Spectrom 19:1460–1467.
   Web of Science ®Google Scholar
• Fängström B, Hamadani J, Nermell B, Grandér M, Palm B, Vahter M. 2009. Impaired arsenic metabolism in children during weaning. Toxicol Appl Pharmacol 239:208–214.
   PubMed Web of Science ®Google Scholar
• Farago ME, Kavanagh P. 1999. Proportions of Arsenic Species in Human urine. In: Chappell WR, Abernathy CO, Calderon RL, ed. Arsenic Exposure and Health Effects. Elsevier Sciences B.V. 325–334.
   Google Scholar
• Gong Z, Lu X, Cullen WR, Le XC. 2001. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J Anal At Spectrom 16:1409–1413.
   Web of Science ®Google Scholar
• Hughes M, Kitchin K. (2006). Arsenic, oxidative stress and carcinogenesis. In: Singh K, ed., Oxidative Stress, Disease and Cancer. London: Imperial College press, 825–50.
   Google Scholar
• Hughes MF, Kenyon EM. 1998. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J Toxicol Environ Health Part A 53:95–112.
   PubMed Web of Science ®Google Scholar
• Hughes ML, Carstensen B, Wilkinson JL, Weintraub RG. 2007. Angiographic diagnosis, prevalence and outcomes for left ventricular noncompaction in children with congenital cardiac disease. Cardiol Young 17:56–63
   PubMed Web of Science ®Google Scholar
• Jiang G, Gong Z, Li XF, Cullen WR, Le XC. 2003. Interaction of trivalent arsenicals with metallothionein. Chem Res Toxicol 16:873–880.
   PubMed Web of Science ®Google Scholar
• Kaltreider RC, Davis AM, Lariviere JP, Hamilton JW. 2001. Arsenic alters the function of the glucocorticoid receptor as a transcription factor. Environ Health Perspect 109:245–251.
   PubMed Web of Science ®Google Scholar
• Kenyon EM, Del Razo LM, Hughes MF, Kitchin KT. 2005. An integrated pharmacokinetic and pharmacodynamic study of arsenite action 2. Heme oxygenase induction in mice. Toxicology 206:389–401.
   PubMed Web of Science ®Google Scholar
• Kitchin KT, Wallace K. 2008. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J Inorg Biochem 102:532–539.
   PubMed Web of Science ®Google Scholar
• Le XC, Cullen WR, Reimer KJ. 1994. Speciation of arsenic compounds by HPLC with hydride generation atomic absorption spectrometry and inductively coupled plasma mass spectrometry detection. Talanta 41:495–502.
   PubMed Web of Science ®Google Scholar
• Le XC, Lu X, Ma M, Cullen WR, Aposhian HV, Zheng B. 2000. Speciation of key arsenic metabolic intermediates in human urine. Anal Chem 72:5172–5177.
   PubMed Web of Science ®Google Scholar
• Le XC, Ma M, Cullen WR, Aposhian HV, Lu X, Zheng B. 2000. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 108:1015–1018.
   PubMed Web of Science ®Google Scholar
• Maitra R, Hamilton JW. 2005. Arsenite regulates cystic fibrosis transmembrane conductance regulator and p-glycoprotein: Evidence of pathway independence. Cell Physiol Biochem 16:109–118.
   PubMedGoogle Scholar
• Mandal BK, Ogra Y, Suzuki KT. 2001. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14:371–378.
   PubMed Web of Science ®Google Scholar
• NOM-062-ZOO-1999: Norma Oficial Mexicana “Especificaciones técnicas para la Producción, Cuidado y Uso de los Animales de Laboratorio”. (2001) Diario Oficial del Gobierno Mexicano.
   Google Scholar
• Slejkovec Z, Falnoga I, Goessler W, van Elteren JT, Raml R, Podgornik H, Cernelc P. 2008. Analytical artefacts in the speciation of arsenic in clinical samples. Anal Chim Acta 607:83–91.
   PubMed Web of Science ®Google Scholar
• Soto-Reyes E, Del Razo LM, Valverde M, Rojas E. 2005. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic. Biometals 18:493–506.
   PubMed Web of Science ®Google Scholar
• Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ. 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289–299.
   PubMed Web of Science ®Google Scholar
• Thomas DJ, Li J, Waters SB, Xing W, Adair BM, Drobna Z, Devesa V, Styblo M. 2007. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med (Maywood) 232:3–13.
   PubMed Web of Science ®Google Scholar
• Vahter M, Friberg L, Rahnster B, Nygren A, Nolinder P. 1986. Airborne arsenic and urinary excretion of metabolites of inorganic arsenic among smelter workers. Int Arch Occup Environ Health 57:79–91.
   PubMed Web of Science ®Google Scholar
• Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-Gonzalez MB, Garcia-Montalvo EA, Calderon-Aranda ES, Del Razo LM. 2005. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect 113:250–254.
   PubMed Web of Science ®Google Scholar
• Valenzuela OL, Drobná Z, Hernández-Castellanos E, Sánchez-Peña LC, García-Vargas GG, Borja-Aburto VH, Stýblo M, Del Razo LM. 2009. Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol Appl Pharmacol 239:200–207.
   PubMed Web of Science ®Google Scholar
• Xie R, Johnson W, Spayd S, Hall GS, Buckley B. 2006. Arsenic speciation analysis of human urine using ion exchange chromatography coupled to inductively coupled plasma mass spectrometry. Anal Chim Acta 578:186–194.
   PubMed Web of Science ®Google Scholar
• Walton FS, Harmon AW, Paul DS, Drobná Z, Patel YM, Styblo M. 2004. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: Possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol 198:424–433.
   PubMed Web of Science ®Google Scholar